Ziopharm Oncology and MD Anderson Cancer Center Announce New R&D Agreement to Expand TCR-T Program Read more
CARsgen Announces Investigational CAR-T Therapy CT053 Granted RMAT Designation by the FDA for R/R Multiple Myeloma Read more
Gilead and Glympse Bio Announce Strategic Collaboration for Use of Biomarker Technology in NASH Clinical Development Read more
Exclusive interview from conference speaker Richard Marsden released ahead of SMi’s Respiratory Drug Delivery Conference Read more
Under the Spotlight: Genentech & The RNA Medicines Company Workshops on Drug Discovery Approaches to RNA & Empowering RNA Drug Target Validation Read more